-
Most Americans believe that screening tests for cancer save lives and that it is irresponsible not to undergo recommended periodic screening. The presence of a large market for cancer screening may make Americans vulnerable to unproven and unnecessary testing.
-
Beksinska and colleagues from South Africa measured FSH levels in long-term older users of depot-medroxyprogesterone acetate (117 women) and norethindrone enanthate (60 women), long-acting progestin-only methods of contraception.
-
-
-
Antibiotics Associated With Cancer Risk; Topiramate Effective Against Migraine; Statin Therapy For Heart Failure; FDA Actions.
-
-
To answer the title question a team of british investigators (Banerjee S, et al. Obstet Gynecol. 2004;103:287-293) inserted an intrauterine temperature sensor in 18 laboring patients with epidural anesthesia at the time they were inserting intrauterine pressure catheters. These patients then were monitored with periodic oral thermometer sampling, continuous skin temp assessment (taped to the inner thigh) and the commonly used ear canal temperature assessments.
-
Ninety-five patients with vaginal vault prolapse were randomly assigned to having either an abdominal sacral colpopexy with Prolene mesh or unilateral sacrospinous colpopexy. All patients in both groups with stress incontinence also had Burch colposuspension. The abdominal approach was associated with longer operating room time, higher cost, and longer convalescence.
-
The loss of heterozygosity in the tumor tissue of carriers coupled with the high frequency of patient and family history of breast and ovarian malignancies suggest that USPC might be part of the manifestation of familial breast-ovarian cancer in Ashkenazi Jews.
-
Lindauer and colleagues set out to evaluate whether the tumor-free distance from the uterine serosa to the deepest invasive lesion was a better predictor of patient outcome from endometrial cancer than the traditional measure of myometrial invasion. To do this, they retrospectively evaluated all surgically staged endometrial adenocarcinoma patients between 1997 and 2000.
